Beta Amyloid

信号通路图

研究领域

抑制剂选择性比较

Beta Amyloid产品

所有产品 Beta Amyloid抑制剂(10) 新Beta Amyloid产品

产品目录	产品描述	文献引用	实验数据
S2215	DAPT (GSI-IX) DAPT (GSI-IX)是一种新型γ-secretase抑制剂，抑制 Aβ产生，在HEK 293细胞中IC50为20 nM。	Nature, 2019, 565(7740):505-510 Acta Neuropathol, 2019, 10.1007/s00401-019-01986-1 Cell Res, 2019, 29(2):110-123	Western blotting showing increased unconjugated SUMO1 levels in Notch1 ΔE cells treated with 10 uM DAPT for 3 days. Tubulin was used as a loading control.
S1575	RO4929097 RO4929097是一种γ secretase抑制剂，无细胞试验中IC50为4 nM，抑制Aβ40和Notch的细胞加工，EC50分别为14 nM和5 nM。Phase 2。	Cell Res, 2019, 29(2):110-123 Int J Cancer, 2019, 10.1002/ijc.32293 Mol Cancer Ther, 2019, 18(7):1230-1242
S2660	MK-0752 MK-0752是一种适度有效的γ-secretase（γ-分泌酶）抑制剂，降低Aβ40产量，IC50为5 nM。Phase 1/2。	Neoplasia, 2018, 21(1):93-105 Proc Natl Acad Sci USA, 2017, 114(50):E10782-E10791 Oncol Lett, 2016, 12(4):2900-2905	HES1 expression after treatment with clinically available GSIs R04929097, BMS-708163, LY450139, and MK-0752 as determined by qRT-PCR.
S1262	Avagacestat (BMS-708163) Avagacestat (BMS-708163)是口服生物有效的，选择性的γ-分泌酶抑制剂，作用于Aβ40和Aβ42时，IC50分别为0.3 nM和0.27 nM，比作用于Notch选择性高193倍。Phase 2。	Cancer Cell, 2019, 36(1):68-83 Acta Pharmacol Sin, 2018, 39(2):177-183 Sci Rep, 2016, 6:33427	A panel of GICs lines was treated with various concentrations of γ secretase inhibitors BMS-708163. Cells were treated with increasing concentrations of γ secretase inhibitors in triplicate wells for 72 hours, and cell viability was assessed by CellTiter-Blue assay as described in Materials and Methods. The results shown are of a single experiment with three independent replicates cell viability was measured by CellTiter-Blue assay. The graph depicts cell viability at 72 hours. Cell viability in the vehicle control was considered as to be 100%.
S1528	LY2811376 LY2811376是第一个口服有效的，非肽类β-secretase(BACE1)抑制剂，IC50为239 nM-249 nM，可以减少Aβ分泌，EC50为300 nM，作用于BACE1比作用于BACE2选择性高10倍，比作用于其他天冬氨酸蛋白酶（包括Cathepsin D，胃蛋白酶和肾素）抑制效果高50倍以上。Phase 1。	J Alzheimers Dis, 2017, 55(1):391-410 Exp Cell Res, 2017, 360(2):171-179 PLoS One, 2015, 10(4):e0122451
S6733^New	Edonerpic maleate Edonerpic maleate是一种神经营养性因子，可抑制amyloid-β peptides (Aβ)。
S4261	EUK 134 EUK 134是一种合成的超氧化物歧化酶（SOD）/过氧化氢酶类似物，具有强效的抗氧化活性，且抑制β-amyloid（β-淀粉样蛋白）和相关的淀粉样纤维形成。
S4760	(2-Hydroxypropyl)-β-cyclodextrin (HP-β-CD) HP-β-cyclodextrin (HP-β-CD), a well-known sugar used in drug delivery, genetic vector, environmental protection and treatment of Niemann-Pick disease type C1 (NPC1), is an inhibitor of amyloid-β aggregation.
S5101	Tabersonine hydrochloride Tabersonine, an ingredient extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1−42) aggregation and toxicity.
s9087	Tenuifolin Tenuifolin, a secondary saponin isolated from hydrolysates of polygalasaponins, inhibits beta-amyloid synthesis in vitro and has nootropic activity in vivo via acetylcholine esterase inhibition and increases norepinephrine and dopamine production.

产品目录	产品描述	文献引用	实验数据
S2215	DAPT (GSI-IX) DAPT (GSI-IX)是一种新型γ-secretase抑制剂，抑制 Aβ产生，在HEK 293细胞中IC50为20 nM。	Nature,2019, 565(7740):505-510 Acta Neuropathol,2019, 10.1007/s00401-019-01986-1 Cell Res,2019, 29(2):110-123	Western blotting showing increased unconjugated SUMO1 levels in Notch1 ΔE cells treated with 10 uM DAPT for 3 days. Tubulin was used as a loading control.
S1575	RO4929097 RO4929097是一种γ secretase抑制剂，无细胞试验中IC50为4 nM，抑制Aβ40和Notch的细胞加工，EC50分别为14 nM和5 nM。Phase 2。	Cell Res,2019, 29(2):110-123 Int J Cancer,2019, 10.1002/ijc.32293 Mol Cancer Ther,2019, 18(7):1230-1242
S2660	MK-0752 MK-0752是一种适度有效的γ-secretase（γ-分泌酶）抑制剂，降低Aβ40产量，IC50为5 nM。Phase 1/2。	Neoplasia,2018, 21(1):93-105 Proc Natl Acad Sci USA,2017, 114(50):E10782-E10791 Oncol Lett,2016, 12(4):2900-2905	HES1 expression after treatment with clinically available GSIs R04929097, BMS-708163, LY450139, and MK-0752 as determined by qRT-PCR.
S1262	Avagacestat (BMS-708163) Avagacestat (BMS-708163)是口服生物有效的，选择性的γ-分泌酶抑制剂，作用于Aβ40和Aβ42时，IC50分别为0.3 nM和0.27 nM，比作用于Notch选择性高193倍。Phase 2。	Cancer Cell,2019, 36(1):68-83 Acta Pharmacol Sin,2018, 39(2):177-183 Sci Rep,2016, 6:33427	A panel of GICs lines was treated with various concentrations of γ secretase inhibitors BMS-708163. Cells were treated with increasing concentrations of γ secretase inhibitors in triplicate wells for 72 hours, and cell viability was assessed by CellTiter-Blue assay as described in Materials and Methods. The results shown are of a single experiment with three independent replicates cell viability was measured by CellTiter-Blue assay. The graph depicts cell viability at 72 hours. Cell viability in the vehicle control was considered as to be 100%.
S1528	LY2811376 LY2811376是第一个口服有效的，非肽类β-secretase(BACE1)抑制剂，IC50为239 nM-249 nM，可以减少Aβ分泌，EC50为300 nM，作用于BACE1比作用于BACE2选择性高10倍，比作用于其他天冬氨酸蛋白酶（包括Cathepsin D，胃蛋白酶和肾素）抑制效果高50倍以上。Phase 1。	J Alzheimers Dis,2017, 55(1):391-410 Exp Cell Res,2017, 360(2):171-179 PLoS One,2015, 10(4):e0122451
S6733^New	Edonerpic maleate Edonerpic maleate是一种神经营养性因子，可抑制amyloid-β peptides (Aβ)。
S4261	EUK 134 EUK 134是一种合成的超氧化物歧化酶（SOD）/过氧化氢酶类似物，具有强效的抗氧化活性，且抑制β-amyloid（β-淀粉样蛋白）和相关的淀粉样纤维形成。
S4760	(2-Hydroxypropyl)-β-cyclodextrin (HP-β-CD) HP-β-cyclodextrin (HP-β-CD), a well-known sugar used in drug delivery, genetic vector, environmental protection and treatment of Niemann-Pick disease type C1 (NPC1), is an inhibitor of amyloid-β aggregation.
S5101	Tabersonine hydrochloride Tabersonine, an ingredient extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1−42) aggregation and toxicity.
s9087	Tenuifolin Tenuifolin, a secondary saponin isolated from hydrolysates of polygalasaponins, inhibits beta-amyloid synthesis in vitro and has nootropic activity in vivo via acetylcholine esterase inhibition and increases norepinephrine and dopamine production.